Cancer Immunotherapy: Molecular Research and Application
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 15 December 2026 | Viewed by 105
Special Issue Editors
Interests: cancer immunotherapy; cell death mechanisms; mitochondrial dynamics; energy metabolism
Interests: cancer immunology; cell biology; apoptosis; autoimmunity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, advances in molecular biology, immunology, and biotechnology have significantly enhanced our understanding of tumor–immune system interactions. Breakthroughs such as immune checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines have demonstrated the potential of immunotherapy to achieve durable responses in various malignancies. However, important challenges remain, including treatment resistance, limited efficacy across cancer types, and immune-related adverse effects.
We are pleased to invite you to contribute to a forthcoming Special Issue entitled ‘Cancer Immunotherapy: Molecular Research and Application’. This collection aims to gather high-quality original research, reviews, and perspectives that address both fundamental mechanisms and clinical applications of cancer immunotherapy. We particularly welcome contributions exploring novel molecular targets, biomarkers for patient stratification, combination therapies, and translational approaches bridging laboratory findings with clinical practice.
Given the rapid evolution of this field and its critical role in shaping the future of cancer treatment, continued research is essential. Your contribution will help advance knowledge and, ultimately, support the development of more effective and accessible therapies.
Dr. Joaquin Marco-Brualla
Prof. Dr. Alberto Anel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunotherapy
- immunomodulation
- drug discovery
- molecular mechanisms
- combination therapies
- translational research
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
